KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Equity (2016 - 2025)

Eli Lilly (LLY) has disclosed Return on Equity for 16 consecutive years, with 0.82% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 67.0% year-over-year to 0.82%, compared with a TTM value of 0.82% through Dec 2025, down 67.0%, and an annual FY2025 reading of 1.01%, down 41.0% over the prior year.
  • Return on Equity was 0.82% for Q4 2025 at Eli Lilly, down from 1.67% in the prior quarter.
  • Across five years, Return on Equity topped out at 20.71% in Q1 2021 and bottomed at 6.51% in Q4 2022.
  • Average Return on Equity over 5 years is 1.08%, with a median of 1.14% recorded in 2022.
  • The sharpest move saw Return on Equity tumbled -1827bps in 2022, then skyrocketed 786bps in 2023.
  • Year by year, Return on Equity stood at 2.98% in 2021, then plummeted by -118bps to 6.51% in 2022, then soared by 121bps to 1.35% in 2023, then grew by 10bps to 1.49% in 2024, then tumbled by -45bps to 0.82% in 2025.
  • Business Quant data shows Return on Equity for LLY at 0.82% in Q4 2025, 1.67% in Q3 2025, and 5.36% in Q2 2025.